MyJournals Home  

RSS FeedsDopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects (Neuropsychopharmacology)

 
 

2 december 2018 08:00:19

 
Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects (Neuropsychopharmacology)
 




 
123 viewsCategory: Neurology, Psychology, Pharmacology
 
Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation (Neuropsychopharmacology)
NIDA`s medication development priorities in response to the Opioid Crisis: ten most wanted (Neuropsychopharmacology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten